219 related articles for article (PubMed ID: 24732361)
1. LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR.
Russe OQ; Möser CV; Kynast KL; King TS; Olbrich K; Grösch S; Geisslinger G; Niederberger E
Biochem Biophys Res Commun; 2014 May; 447(3):520-5. PubMed ID: 24732361
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M
Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081
[TBL] [Abstract][Full Text] [Related]
4. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
[TBL] [Abstract][Full Text] [Related]
7. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
[TBL] [Abstract][Full Text] [Related]
9. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
10. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
11. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
12. Activation of the AMP-activated protein kinase reduces inflammatory nociception.
Russe OQ; Möser CV; Kynast KL; King TS; Stephan H; Geisslinger G; Niederberger E
J Pain; 2013 Nov; 14(11):1330-40. PubMed ID: 23916727
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice.
Zhou D; Ai Q; Lin L; Gong X; Ge P; Che Q; Wan J; Wen A; Zhang L
Innate Immun; 2015 Oct; 21(7):698-705. PubMed ID: 25979627
[TBL] [Abstract][Full Text] [Related]
14. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
[TBL] [Abstract][Full Text] [Related]
15. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
[TBL] [Abstract][Full Text] [Related]
16. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
[TBL] [Abstract][Full Text] [Related]
17. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.
Kim WG; Choi HJ; Kim TY; Shong YK; Kim WB
Korean J Intern Med; 2014 Jul; 29(4):474-81. PubMed ID: 25045295
[TBL] [Abstract][Full Text] [Related]
18. AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages.
Kirchner J; Brüne B; Namgaladze D
Sci Rep; 2018 May; 8(1):7801. PubMed ID: 29773845
[TBL] [Abstract][Full Text] [Related]
19. The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.
Choi HJ; Kim TY; Chung N; Yim JH; Kim WG; Kim JA; Kim WB; Shong YK
J Endocrinol; 2011 Oct; 211(1):79-85. PubMed ID: 21795305
[TBL] [Abstract][Full Text] [Related]
20. AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Su CC; Hsieh KL; Liu PL; Yeh HC; Huang SP; Fang SH; Cheng WC; Huang KH; Chiu FY; Lin IL; Huang MY; Li CY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]